Previous
Next
Welcome to collaborative research.
Where science, technology
and translation converge
Our formula to develop trailblazing drugs and advance health sciences is based on extreme collaboration between three hubs: ambitious scientific research, ever-evolving technological innovation and a constant translational effort of carrying our breakthroughs from bench to bedside.
Latest breakthroughs
Innovation in medicine is happening right now. Keep up with us.
Gomes RFA, Ravasco JMJM, Andrade KHS, Coelho JAS, Moreira R, Oliveira R, Nogueira F, Afonso CAM. Tandem Thio-Michael Addition/Remote Lactone Activation of 5-Hydroxymethylfurfural-Derived δ-Lactone-Fused Cyclopentenones. ChemSusChem. 2022; e202102204. DOI: 10.1002/cssc.202102204.
- April 27, 2022
- Bioorganic Chemistry
Vale FF, Vítor J, Marques AT, Azevedo-Pereira JM, Anes E, Goncalves J. Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide. Virus Res. 2021; 304, 198526. DOI: 10.1016/j.virusres.2021.198526.
- October 15, 2021
- Molecular Microbiology and Biotechnology
Fernandez-Checa JC, Bagnaninchi P, Ye H, Sancho-Bru P, Falcon-Perez JM, Royo F, Garcia-Ruiz C, Konu O, Miranda J, Lunov O, Dejneka A, Elfick A, McDonald A, Sullivan GJ, Aithal GP, Lucena MI, Andrade RJ, Fromenty B, Kranendonk M, Cubero FJ, Nelson LJ. Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]. J Hepatol. 2021; 75 (4): 935-959. DOI: 10.1016/j.jhep.2021.06.021
Partners
iMed is a FCT funded research centre but we don't act alone. Every in-house member at imed advances our purpose but we also collaborate with some distinguished external partners.
ULisboa
Faculdade de Farmácia
FCT
República Portuguesa
Example Title
